Prof Matti Aapro (Genolier Cancer Centre, Switzerland) and Prof Nicolas Mottet (University Hospital St Etienne, France) talk to ecancer for an overview discussion of the treatment of prostate cancer in elderly patients during the COVID-19 pandemic.
They begin with an overview of the impact of COVID-19 pandemic on prostate cancer patients. Prof Mottet explains the main issues, including under-diagnosis and reluctance from patients to make hospital visits.
The conversation moves on to guidelines, firstly the cooperation between SIOG and the EAU, and secondly the best recommendations given to aid those guidelines.
The doctors then move on to discuss treatment in this unusual setting. This includes recommendations from SIOG, and also management of patients during the pandemic.
This service has been kindly supported by an unrestricted grant from Janssen Oncology